MaaT Pharma Announces Ordinary and Extraordinary Shareholders’ General Meeting on March 3, 2022, and the…
MaaT PharmaJanuary 26, 2022
Alliance Promotion Microbiote devient une Association et poursuit la structuration de la filière française du…
MaaT PharmaJanuary 20, 2022
MaaT Pharma Provides Business Objectives and Expected Milestones for 2022 Important clinical milestones are expected…
MaaT PharmaJanuary 17, 2022
MaaT Pharma Announces Initiation of Coverage of its Stock by KBC Securities, Kempen and Portzamparc/Groupe…
MaaT PharmaJanuary 13, 2022
Lyon, France, January 3, 2022 - 7:00 pm CET – MaaT Pharma (EURONEXT: MAAT -…
MaaT PharmaJanuary 3, 2022
Ce communiqué ne peut être distribué directement ou indirectement aux Etats-Unis d’Amérique, au Canada, en…
MaaT PharmaJanuary 3, 2022
MaaT Pharma Presents Promising Clinical Data from 76 Patients with Acute Graft-vs-Host-Disease Treated with MaaT013…
MaaT PharmaDecember 11, 2021
MaaT Pharma S.A. (« MaaT Pharma » ou la « Société »), société française de…
MaaT PharmaDecember 6, 2021
This announcement is not being made in and copies of it shall not be distributed…
MaaT PharmaDecember 6, 2021
